Literature DB >> 9879775

Estimate of tumor growth time for breast cancer local recurrences: rapid growth after wake-up?

R Demicheli1, M Terenziani, G Bonadonna.   

Abstract

To obtain an estimate of the subclinical tumor growth time (TGT) for breast cancer, a series of 31 patients with local recurrence as first event after mastectomy was evaluated. The recurrence diameter was measured, and the minimum growth rate (mGR) consistent with the sequence 'no detection at the preceding physical examination-->recurrence of diameter Dr' was obtained. The growth rate for uninterrupted exponential growth from surgery (GRu) was also calculated. mGR was significantly higher than GRu (p < 0.0001), and unrelated to the recurrence-free survival (RFS). Therefore, starting points of local recurrence growth curves had to be set at times variously delayed after mastectomy. The estimate of the delay lower limit (mD), which was obtained from mGR and GRu, showed a strong linear correlation with RFS (R = 0.984; p < 0.0001). From the regression equation, TGT for local recurrences could be estimated at 30+/-8 weeks or less. These findings support the concept that the lag time between surgical treatment of breast cancer and clinical evidence of local recurrence may be explained by a period of tumor dormancy followed by a tumor growing phase. The TGT estimate is remarkably shorter than previously believed and could considerably change the current picture of breast cancer history.

Entities:  

Mesh:

Year:  1998        PMID: 9879775     DOI: 10.1023/a:1005887422022

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  15 in total

Review 1.  Does tumour dormancy offer a therapeutic target?

Authors:  Paul E Goss; Ann F Chambers
Journal:  Nat Rev Cancer       Date:  2010-11-04       Impact factor: 60.716

2.  Mathematical model of the role of intercellular signalling in intercellular cooperation during tumorigenesis.

Authors:  S Ghosh; S Elankumaran; I K Puri
Journal:  Cell Prolif       Date:  2011-04       Impact factor: 6.831

3.  The molecular genomics of metastatic brain tumours.

Authors:  A Bollig-Fischer; Sk Michelhaugh; R Ali-Fehmi; S Mittal
Journal:  OA Mol Oncol       Date:  2013-04-01

Review 4.  Mechanisms of Cancer Cell Dormancy--Another Hallmark of Cancer?

Authors:  Albert C Yeh; Sridhar Ramaswamy
Journal:  Cancer Res       Date:  2015-09-09       Impact factor: 12.701

5.  Genomic analysis of circulating cell-free DNA infers breast cancer dormancy.

Authors:  Jacqueline A Shaw; Karen Page; Kevin Blighe; Natasha Hava; David Guttery; Becky Ward; James Brown; Chetana Ruangpratheep; Justin Stebbing; Rachel Payne; Carlo Palmieri; Suzy Cleator; Rosemary A Walker; R Charles Coombes
Journal:  Genome Res       Date:  2011-10-11       Impact factor: 9.043

6.  Immune, endocrine, and behavioral precursors to breast cancer recurrence: a case-control analysis.

Authors:  Lisa M Thornton; Barbara L Andersen; William E Carson
Journal:  Cancer Immunol Immunother       Date:  2008-03-08       Impact factor: 6.968

7.  Menopausal status dependence of the timing of breast cancer recurrence after surgical removal of the primary tumour.

Authors:  Romano Demicheli; Gianni Bonadonna; William J M Hrushesky; Michael W Retsky; Pinuccia Valagussa
Journal:  Breast Cancer Res       Date:  2004-10-11       Impact factor: 6.466

8.  What can be learnt about disease progression in breast cancer dormancy from relapse data?

Authors:  Lisa Willis; Trevor A Graham; Tomás Alarcón; Malcolm R Alison; Ian P M Tomlinson; Karen M Page
Journal:  PLoS One       Date:  2013-05-06       Impact factor: 3.240

9.  Promising development from translational or perhaps anti-translational research in breast cancer.

Authors:  Michael Retsky; Romano Demicheli; William Jm Hrushesky; Patrice Forget; Marc De Kock; Isaac Gukas; Rick A Rogers; Michael Baum; Katharine Pachmann; Jayant S Vaidya
Journal:  Clin Transl Med       Date:  2012-08-28

10.  Tumour dormancy in breast cancer: an update.

Authors:  Muriel Brackstone; Jason L Townson; Ann F Chambers
Journal:  Breast Cancer Res       Date:  2007       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.